Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled mul...
Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial
About this item
Full title
Author / Creator
Haeberle, Helene A. , Calov, Stefanie , Martus, Peter , Serna-Higuita, Lina Maria , Koeppen, Michael , Goll, Almuth , Bernard, Alice , Zarbock, Alexander , Meersch, Melanie , Weiss, Raphael , Mehrländer, Martin , Marx, Gernot , Putensen, Christian , Bakchoul, Tamam , Magunia, Harry , Nieswandt, Bernhard , Mirakaj, Valbona and Rosenberger, Peter
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Acute respiratory distress syndrome (ARDS) results in significant hypoxia, and ARDS is the central pathology of COVID-19. Inhaled prostacyclin has been proposed as a therapy for ARDS, but data regarding its role in this syndrome are unavailable. Therefore, we investigated whether inhaled prostacyclin would affect the oxygenation and survival of pat...
Alternative Titles
Full title
Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial
Authors, Artists and Contributors
Author / Creator
Calov, Stefanie
Martus, Peter
Serna-Higuita, Lina Maria
Koeppen, Michael
Goll, Almuth
Bernard, Alice
Zarbock, Alexander
Meersch, Melanie
Weiss, Raphael
Mehrländer, Martin
Marx, Gernot
Putensen, Christian
Bakchoul, Tamam
Magunia, Harry
Nieswandt, Bernhard
Mirakaj, Valbona
Rosenberger, Peter
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b90bd6e37cc64ef991e475ec1d9c972e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b90bd6e37cc64ef991e475ec1d9c972e
Other Identifiers
ISSN
1465-993X,1465-9921
E-ISSN
1465-993X,1465-9921
DOI
10.1186/s12931-023-02346-0
